GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin
Status:
Completed
Trial end date:
2003-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of an oral investigational drug in
patients with refractory metastatic colorectal cancer after receiving prior therapy with
5-fluorouracil in combination with irinotecan and/or oxaliplatin.